Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Htgc Q4 Earnings Misses Estimates By 0.02 20260403 Inflation Continues to Rise in April as Iran Conflict Drives Energy Prices Higher Anika ANIK Q1 2026 Earnings 027 EPS Surges Past 016 Estimates Venture Capital Turns to Boring Businesses How AI and Dealflow Are Reshaping Accounting and Property Management Fed Dissenters Voice Objections to Policy Statements RateCut Signal X Corp Fined A650000 for NonCompliance with Australian Child Protection Laws Singapores Straits Times Index Edges Up 002 as Gainers Lead Losers Extended Carrier Deployments A New Normal for US Navy Operations Sanara MedTech SMTI Q1 2026 Earnings Beat Revenue NA EPS 005 Advanced Painting Pty Ltd Highlights Key Residential Painting Challenges and Repainting Trends in Sydney SpaceX Successfully Launches Starship in Second Attempt Marking Milestone for Space Economy Understanding Bad Credit Personal Loans Key Information for Borrowers Studds Accessories Reports 6 Profit Growth in Q4 FullYear Net Profit Up 187 to 827 Crore SpaceX Scrubs 12th Starship Test Flight Schedules Retry for Friday Amid Program Milestones Mortgage Rates Mixed as of May 24 2026 30Year Fixed Dips 15Year Rises YALA Q1 2026 Earnings EPS of 016 Drives 165 Stock Gain Despite Limited Data GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported TTEK Q1 2026 Earnings EPS Beats Estimates by 417 Stock Rises Slightly GSI Technology Q1 2026 Earnings EPS Loss of 013 Triggers 421 Stock Gain Amid Limited Disclosures CBRL Q1 2026 Earnings Profitability Surprises with EPS of 025 vs Expected Loss FTAIM Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Corpay Inc CPAY Holds Steady Near Midpoint as Consolidation Continues Allegiant Travel ALGT Surges 86 as Value Airline Rebounds Sharply CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain Five Point Holdings FPH Edges Lower as Stock Tests Key Support at 468 BioVie Inc BIVI Faces Selling Pressure as Shares Slide 59